Northern Trust’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.7M Sell
409,394
-1,575
-0.4% -$164K 0.01% 1201
2025
Q1
$47.9M Buy
410,969
+8,469
+2% +$988K 0.01% 1108
2024
Q4
$34.1M Buy
402,500
+69,918
+21% +$5.92M ﹤0.01% 1370
2024
Q3
$29.9M Buy
332,582
+8,089
+2% +$727K ﹤0.01% 1370
2024
Q2
$26.1M Sell
324,493
-11,592
-3% -$933K ﹤0.01% 1389
2024
Q1
$26.8M Sell
336,085
-7,223
-2% -$576K ﹤0.01% 1390
2023
Q4
$27.3M Sell
343,308
-5,749
-2% -$458K ﹤0.01% 1398
2023
Q3
$24.4M Buy
349,057
+22,916
+7% +$1.6M ﹤0.01% 1412
2023
Q2
$23.4M Buy
326,141
+8,089
+3% +$581K ﹤0.01% 1480
2023
Q1
$19.6M Buy
318,052
+6,107
+2% +$377K ﹤0.01% 1560
2022
Q4
$24.1M Buy
311,945
+23,993
+8% +$1.85M 0.01% 1412
2022
Q3
$12.8M Buy
287,952
+7,701
+3% +$344K ﹤0.01% 1807
2022
Q2
$10.7M Sell
280,251
-458
-0.2% -$17.5K ﹤0.01% 1979
2022
Q1
$11.6M Sell
280,709
-10,590
-4% -$438K ﹤0.01% 2054
2021
Q4
$11M Buy
291,299
+14,049
+5% +$531K ﹤0.01% 2166
2021
Q3
$9.14M Sell
277,250
-12,880
-4% -$425K ﹤0.01% 2345
2021
Q2
$19.6M Sell
290,130
-14,292
-5% -$964K ﹤0.01% 1895
2021
Q1
$17.2M Sell
304,422
-13,608
-4% -$771K ﹤0.01% 1935
2020
Q4
$25.9M Sell
318,030
-34,703
-10% -$2.83M 0.01% 1620
2020
Q3
$25.1M Sell
352,733
-22,506
-6% -$1.6M 0.01% 1453
2020
Q2
$30.9M Buy
375,239
+19,741
+6% +$1.62M 0.01% 1276
2020
Q1
$20.9M Buy
355,498
+22,931
+7% +$1.35M 0.01% 1366
2019
Q4
$34.4M Sell
332,567
-580
-0.2% -$59.9K 0.01% 1292
2019
Q3
$6.74M Buy
333,147
+242,884
+269% +$4.92M ﹤0.01% 2379
2019
Q2
$2.33M Buy
90,263
+54,905
+155% +$1.41M ﹤0.01% 3000
2019
Q1
$503K Buy
35,358
+4,843
+16% +$68.9K ﹤0.01% 3537
2018
Q4
$86K Hold
30,515
﹤0.01% 3954
2018
Q3
$105K Hold
30,515
﹤0.01% 4018
2018
Q2
$97K Hold
30,515
﹤0.01% 4025
2018
Q1
$75K Sell
30,515
-3,477
-10% -$8.55K ﹤0.01% 4025
2017
Q4
$190K Sell
33,992
-974
-3% -$5.44K ﹤0.01% 3831
2017
Q3
$194K Hold
34,966
﹤0.01% 3806
2017
Q2
$192K Sell
34,966
-77,233
-69% -$424K ﹤0.01% 3806
2017
Q1
$437K Buy
112,199
+6,966
+7% +$27.1K ﹤0.01% 3571
2016
Q4
$711K Buy
105,233
+276
+0.3% +$1.87K ﹤0.01% 3441
2016
Q3
$827K Buy
104,957
+83,265
+384% +$656K ﹤0.01% 3400
2016
Q2
$164K Buy
+21,692
New +$164K ﹤0.01% 3769